» Authors » Thomas Xue

Thomas Xue

Explore the profile of Thomas Xue including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 16
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou H, Ren Y, Zou K, Jin Y, Liu H, Jiang H, et al.
Adv Healthc Mater . 2024 Nov; 14(3):e2403261. PMID: 39604325
Implant-associated Staphylococcus aureus (S. aureus) osteomyelitis (IASO) leads to high orthopedic implant failure rates due to the formation of Staphylococcal abscess community within the bone marrow and bacterial colonization in...
2.
Jin Y, Liu H, Chu L, Yang J, Li X, Zhou H, et al.
Bioact Mater . 2024 Jul; 40:148-167. PMID: 38962659
Implant-associated () osteomyelitis is a severe challenge in orthopedics. While antibiotic-loaded bone cement is a standardized therapeutic approach for osteomyelitis, it falls short in eradicating Staphylococcus abscess communities (SACs) and...
3.
Lekkala S, Ren Y, Weeks J, Lee K, Tay A, Liu B, et al.
PLoS One . 2024 Jun; 19(6):e0296140. PMID: 38900759
Implant-associated osteomyelitis remains a major orthopaedic problem. As neutrophil swarming to the surgical site is a critical host response to prevent infection, visualization and quantification of this dynamic behavior at...
4.
Lekkala S, Ren Y, Weeks J, Lee K, Tay A, Liu B, et al.
bioRxiv . 2023 Dec; PMID: 38105961
Implant-associated osteomyelitis remains a major orthopaedic problem. As neutrophil swarming to the surgical site is a critical host response to prevent infection, visualization and quantification of this dynamic behavior at...
5.
Ren Y, Weeks J, Xue T, Rainbolt J, Bentley K, Shu Y, et al.
Bone Res . 2023 Oct; 11(1):51. PMID: 37848449
Eradication of MRSA osteomyelitis requires elimination of distinct biofilms. To overcome this, we developed bisphosphonate-conjugated sitafloxacin (BCS, BV600072) and hydroxybisphosphonate-conjugate sitafloxacin (HBCS, BV63072), which achieve "target-and-release" drug delivery proximal to...
6.
Xie C, Ren Y, Weeks J, Rainbolt J, Kenney H, Xue T, et al.
J Orthop Res . 2023 Oct; 42(3):531-538. PMID: 37812184
Critical knowledge gaps of orthopedic infections pertain to bacterial colonization. The established dogma termed the Race for the Surface posits that contaminating bacteria compete with host cells for the implant...
7.
Xie C, Ren Y, Weeks J, Xue T, Rainbolt J, Bentley K, et al.
Res Sq . 2023 May; PMID: 37214929
Eradication of MRSA osteomyelitis requires elimination of distinct biofilms. To overcome this, we developed bisphosphonate-conjugated sitafloxacin (BCS, BV600072) and hydroxybisphosphonate-conjugate sitafloxacin (HBCS, BV63072), which achieve "target-and-release" drug delivery proximal to...
8.
Ren Y, Zhang S, Weeks J, Moreno J, He B, Xue T, et al.
J Orthop Res . 2023 Mar; 41(11):2384-2393. PMID: 36970754
While recent studies showed that macrophages are critical for bone fracture healing, and lack of M2 macrophages have been implicated in models of delayed union, functional roles for specific M2...
9.
Ren Y, Xue T, Rainbolt J, Bentley K, Galloway C, Liu Y, et al.
Front Cell Infect Microbiol . 2022 Jul; 12:910970. PMID: 35811672
infection of bone is difficult to eradicate due to its ability to colonize the osteocyte-lacuno-canalicular network (OLCN), rendering it resistant to standard-of-care (SOC) antibiotics. To overcome this, we proposed two...